CYP1B1 (Leu432Val)
|
ERCC1 (Asn118Asn)
|
N
|
pCR
|
OR
|
95% CI
|
P value
|
---|
n
|
%a
|
---|
CC
|
TT
|
19
|
2
|
10.5
|
1
|
Reference
| |
CC
|
CT
|
22
|
11
|
50.0
|
16.1
|
(2.3–112)
|
0.005
|
CC
|
CC
|
6
|
1
|
16.7
|
2.8
|
(0.16–47)
|
0.48
|
CG
|
TT
|
15
|
1
|
6.7
|
0.41
|
(0.03–5.6)
|
0.51
|
CG
|
CT
|
20
|
2
|
10.0
|
0.77
|
(0.09–6.8)
|
0.81
|
CG
|
CC
|
10
|
2
|
20.0
|
2.4
|
(0.24–25)
|
0.45
|
GG
|
TT
|
6
|
1
|
16.7
|
0.89
|
(0.06–13.5)
|
0.93
|
GG
|
CT
|
8
|
3
|
37.5
|
4.4
|
(0.46–41)
|
0.20
|
GG
|
CC
|
7
|
2
|
28.6
|
3.1
|
(0.28–34)
|
0.35
|
ER−
| |
42
|
15
| |
1
|
Reference
| |
ER+
| |
71
|
10
| |
0.12
|
(0.03–0.43)
|
0.001
|
- Significant results are shown in italic.
-
pCR pathological complete response.
-
aPercentages of evaluable patients.